2024-10-09 |
2024-10-08 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
5,431
+169.3%
0.91
USD 4,942
|
5,431
+169.3%
|
0.91
|
USD 4,942
|
|
2023-09-28 |
2023-09-27 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+4.5%
1.02
USD 2,550
|
2,500
+4.5%
|
1.02
|
USD 2,550
|
|
2023-09-27 |
2023-09-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+4.7%
0.90
USD 2,250
|
2,500
+4.7%
|
0.90
|
USD 2,250
|
|
2023-04-27 |
2023-04-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,497
+27.2%
1.77
USD 2,650
|
1,497
+27.2%
|
1.77
|
USD 2,650
|
|
2023-04-26 |
2023-04-25 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,315
+31.3%
1.89
USD 2,485
|
1,315
+31.3%
|
1.89
|
USD 2,485
|
|
2022-07-27 |
2022-07-27 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+1.1%
0.38
USD 950
|
2,500
+1.1%
|
0.38
|
USD 950
|
|
2022-07-26 |
2022-07-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+1.1%
0.37
USD 935
|
2,500
+1.1%
|
0.37
|
USD 935
|
|
2022-07-26 |
2022-07-26 |
B
Purchase
|
Hamill John P.
SVP & CFO
Officer
|
3,000
+4.3%
0.37
USD 1,100
|
3,000
+4.3%
|
0.37
|
USD 1,100
|
|
2022-07-05 |
2022-06-30 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
4,500
+2.1%
0.43
USD 1,926
|
4,500
+2.1%
|
0.43
|
USD 1,926
|
|
2022-03-17 |
2022-03-16 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,000
+1.0%
0.98
USD 1,960
|
2,000
+1.0%
|
0.98
|
USD 1,960
|
|
2022-03-15 |
2022-03-15 |
B
Purchase
|
Simonson Steven
SVP, Chief Medical Officer
Officer
|
5,000
+6.4%
1.00
USD 4,999
|
5,000
+6.4%
|
1.00
|
USD 4,999
|
|
2022-03-15 |
2022-03-15 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+1.5%
0.98
USD 2,940
|
3,000
+1.5%
|
0.98
|
USD 2,940
|
|
2022-01-10 |
2021-12-30 |
S
Sale
|
Bioengine Capital Inc.
Large shareholder
|
1,239,088
-100.0%
1.60
USD 1,982,541
|
1,239,088
-100.0%
|
1.60
|
USD 1,982,541
|
|
2022-01-10 |
2021-12-30 |
B
Purchase
|
Center Laboratories, Inc.
Large shareholder
|
1,239,088
+inf%
1.60
USD 1,982,541
|
1,239,088
+inf%
|
1.60
|
USD 1,982,541
|
|
2021-11-22 |
2021-11-19 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
930
+2.5%
1.60
USD 1,488
|
930
+2.5%
|
1.60
|
USD 1,488
|
|
2021-11-18 |
2021-11-18 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
930
+2.6%
1.61
USD 1,497
|
930
+2.6%
|
1.61
|
USD 1,497
|
|
2021-10-25 |
2021-10-22 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+9.0%
1.90
USD 5,700
|
3,000
+9.0%
|
1.90
|
USD 5,700
|
|
2021-10-19 |
2021-10-19 |
B
Purchase
|
Huang James
Non-Executive Director
|
50,000
+20.7%
1.90
USD 95,135
|
50,000
+20.7%
|
1.90
|
USD 95,135
|
|
2021-10-19 |
2021-10-19 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+9.9%
1.91
USD 5,730
|
3,000
+9.9%
|
1.91
|
USD 5,730
|
|
2021-04-20 |
2021-04-16 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,000
+3.4%
2.09
USD 2,092
|
1,000
+3.4%
|
2.09
|
USD 2,092
|
|